IndexMethodologyInsightsFor CliniciansRequest Review
⚠️
This device has not received regulatory clearance
This listing is based on publicly available information and has not been verified by the manufacturer or any regulatory authority.
Index/Pipeline/Ruijin Hospital
ALT-006155Pre-approval

ROSE-AI diagnostic system

Ruijin Hospital · Sponsor


Regulatory Pipeline
1
Proof of Concept
2
Development
3
Clinical Trial
4
Pre-submission
5
Submitted
6
Under Review
7
Cleared
All identifiers (2)
Aletia (canonical)ALT-006155
ClinicalTrials.gov (primary)NCT06824909
Trial signal only — manufacturer hasn't claimed this listing yet.
The trial data below was imported from ClinicalTrials.gov. If you represent Ruijin Hospital, you can claim this listing to add funding, team, and contact details.
Claim this listing →

Clinical Trial Signal

NCT06824909
recruiting
内镜超声穿刺胰腺实性占位细胞涂片快速染色后全玻片扫描及人工智能诊断:一项前瞻性、多中心研究
Phase: na1500 enrolledCN

Investor Interest

Signal to the team that this device is on your radar. Anonymous — the manufacturer sees the count, not your identity.

0
investors
← Back to Index